The treatment of atrial fibrillation: Pharmacologic and nonpharmacologic strategies
- 1 February 1997
- journal article
- review article
- Published by Elsevier in Current Problems in Cardiology
- Vol. 22 (2) , 37-108
- https://doi.org/10.1016/s0146-2806(97)80014-x
Abstract
No abstract availableThis publication has 209 references indexed in Scilit:
- Efficacy of Ajmaline and Propafenone in Patients with Accessory PathwaysJournal of Cardiovascular Pharmacology, 1994
- Effect of Magnesium Sulfate on Ventricular Rate Control in Atrial FibrillationAnnals of Emergency Medicine, 1994
- Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug TherapyNew England Journal of Medicine, 1988
- The Natural History of Lone Atrial FibrillationNew England Journal of Medicine, 1987
- Diltiazem, Verapamil, and Quinidine in Patients With Chronic Atrial FibrillationThe Journal of Clinical Pharmacology, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Hypotension after Quinidine plus VerapamilNew England Journal of Medicine, 1985
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.Circulation, 1977
- Factors Influencing Conversion of Chronic Atrial Fibrillation with Special Reference to Serum Quinidine ConcentrationCirculation, 1956